Clinical Neuropharmacology

Aims & Scope

Clinical Neuropharmacology is a peer-reviewed journal devoted to the pharmacology of the nervous system in its broadest sense.

Coverage ranges from such basic aspects as mechanisms of action, structure-activity relationships, and drug metabolism and pharmacokinetics, to practical clinical problems such as drug interactions, drug toxicity, and therapy for specific syndromes and symptoms.

The journal publishes original articles and brief reports, invited and submitted reviews, and letters to the editor.

A regular feature is the Patient Management Series: in-depth case presentations with clinical questions and answers.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	1.5
2024	0.80

SJR (SCImago Journal Rank)

Year	Value
2024	0.326

Quartile

Year	Value
2024	Q3

h-index

Year	Value
2024	87

Journal Rank

Year	Value
2024	15841

Journal Citation Indicator

Year	Value
2024	172

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Mechanism of Action of Oral Fingolimod (FTY720) in Multiple Sclerosis

  Citation: 673

  Authors: Jerold, Hans-Peter

• Acute Spinal Cord Injury, Part I: Pathophysiologic Mechanisms

  Citation: 579

  Authors: Randall J., David O., Subodh, R. John, Paul T., Dilantha B., Aaron S.

• Pharmacological Mechanisms of Opioid Analgesics

  Citation: 429

  Authors: Gavril W.

• The Nighttime Problems of Parkinsonʼs Disease

  Citation: 334

  Authors: Andrew J., Nigel A., Vivien L.

• Pharmacokinetics of Levodopa

  Citation: 261

  Authors: John G., Jack H.

• A Home Diary to Assess Functional Status in Patients with Parkinson's Disease with Motor Fluctuations and Dyskinesia

  Citation: 254

  Authors: Robert A., Jeffrey, Theresa A., Charles H., Lauren C., Christopher F., Eric S., Stewart A.

• A “Glutamatergic Hypothesis” of Schizophrenia

  Citation: 207

  Authors: Stephen I., John, Barbara L., Richard B., John M.

• MPTP

  Citation: 196

  Authors: J. William, Ian

• Optimizing Levodopa Pharmacokinetics: Intestinal Infusion Versus Oral Sustained-Release Tablets

  Citation: 194

  Authors: Dag, HÃ¥kan, Cecilia, Tina, Hans, Christer, Sten-Magnus

• Sleep Disruption in the Course of Chronic Levodopa Therapy

  Citation: 191

  Authors: Paul A., William J., Linda R., Steven, Harold L.

---